Nov 8 2011
Oxford Expression Technologies launches US hub
In order to provide a first class service for our US customers, Oxford Expression Technologies (OET) has opened a new US hub in San Diego.
In order to provide a first class service for our US customers, Oxford Expression Technologies (OET) has opened a new US hub in San Diego.
15th June 2011 Oxford (UK): Oxford Expression Technologies, the award-winning specialist provider of baculovirus-based protein expression solutions, now applies its expertise to the production of recombinant vaccines, particularly in the field of virus like particle (VLP) vaccines. VLP vaccines represent the next generation of treatment methodologies; the VLP platform offers huge potential for use as a highly effective antiviral vaccine.
ProteoNic and Oxford Expression Technologies join forces combining UNic™ with flashBAC™ protein expression platform Leiden, Netherlands/Oxford, United Kingdom – ProteoNic BV, the protein production experts, and Oxford Expression Technologies Ltd (OET), a leading provider of baculovirus-based protein expression products and services, have joined forces in the field of recombinant protein production technology with the aim of jointly offering a superior platform and services. Several projects combining ProteoNic’s UNic™ translation enhancement elements with OET’s flashBAC™ system have been initiated.
Oxford Expression Technologies has launched baculoFECTIN. This new non-toxic transfection reagent has been optimized for use in insect cells. The reagent offers a high transfection efficiency combined with a simple protocol, and is ideal for use with the flashBAC system.
Oxford Expression Technologies, an award-winning specialist provider of baculovirus-based protein expression solutions, launches pOET3, a novel baculovirus transfer plasmid for improved expression of glycosylated, secreted and membrane-targeted proteins.
Oxford Expression Technologies Ltd (OET), a leading provider of baculovirus-based protein expression products and services, has signed research collaboration agreements with ParaTechs and LifeSensors. The projects aim to enhance and expand OET‟s highly successful flashBAC™ portfolio of baculovirus protein expression systems.
The company has also launched a new range of transfer plasmids with unique signalsequences and promoters.
Oxford Expression Technologies (OET), a leading provider of baculovirus-based protein expression products and services, and Eden Biodesign.
Oxford Expression Technologies has launched baculoXPRESS, a suite of comprehensive baculovirus expression services that can be tailored to individual requirements.
OET Appoints of Business Development Manager and Sales Manager, and Completes Second Round of Funding.
Keep up-to-date with OET's news